These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 8057847)

  • 1. Evolution of antibiotic resistance: several different amino acid substitutions in an active site loop alter the substrate profile of beta-lactamase.
    Palzkill T; Le QQ; Venkatachalam KV; LaRocco M; Ocera H
    Mol Microbiol; 1994 Apr; 12(2):217-29. PubMed ID: 8057847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systematic mutagenesis of the active site omega loop of TEM-1 beta-lactamase.
    Petrosino JF; Palzkill T
    J Bacteriol; 1996 Apr; 178(7):1821-8. PubMed ID: 8606154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A triple mutant in the Ω-loop of TEM-1 β-lactamase changes the substrate profile via a large conformational change and an altered general base for catalysis.
    Stojanoski V; Chow DC; Hu L; Sankaran B; Gilbert HF; Prasad BV; Palzkill T
    J Biol Chem; 2015 Apr; 290(16):10382-94. PubMed ID: 25713062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of amino acid substitutions that alter the substrate specificity of TEM-1 beta-lactamase.
    Palzkill T; Botstein D
    J Bacteriol; 1992 Aug; 174(16):5237-43. PubMed ID: 1644749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selection and characterization of amino acid substitutions at residues 237-240 of TEM-1 beta-lactamase with altered substrate specificity for aztreonam and ceftazidime.
    Cantu C; Huang W; Palzkill T
    J Biol Chem; 1996 Sep; 271(37):22538-45. PubMed ID: 8798421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insertion mutagenesis as a tool in the modification of protein function. Extended substrate specificity conferred by pentapeptide insertions in the omega-loop of TEM-1 beta-lactamase.
    Hayes F; Hallet B; Cao Y
    J Biol Chem; 1997 Nov; 272(46):28833-6. PubMed ID: 9360947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of TEM-1 beta-lactamase mutants from positions 238 to 241 with increased catalytic efficiency for ceftazidime.
    Venkatachalam KV; Huang W; LaRocco M; Palzkill T
    J Biol Chem; 1994 Sep; 269(38):23444-50. PubMed ID: 8089110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A secondary drug resistance mutation of TEM-1 beta-lactamase that suppresses misfolding and aggregation.
    Sideraki V; Huang W; Palzkill T; Gilbert HF
    Proc Natl Acad Sci U S A; 2001 Jan; 98(1):283-8. PubMed ID: 11114163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel extended-spectrum beta-lactamase CTX-M-23 with a P167T substitution in the active-site omega loop associated with ceftazidime resistance.
    Stürenburg E; Kühn A; Mack D; Laufs R
    J Antimicrob Chemother; 2004 Aug; 54(2):406-9. PubMed ID: 15201232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploring the Role of the Ω-Loop in the Evolution of Ceftazidime Resistance in the PenA β-Lactamase from Burkholderia multivorans, an Important Cystic Fibrosis Pathogen.
    Papp-Wallace KM; Becka SA; Taracila MA; Zeiser ET; Gatta JA; LiPuma JJ; Bonomo RA
    Antimicrob Agents Chemother; 2017 Feb; 61(2):. PubMed ID: 27872073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resistance to ceftazidime is associated with a S220Y substitution in the omega loop of the AmpC beta-lactamase of a Serratia marcescens clinical isolate.
    Hidri N; Barnaud G; Decré D; Cerceau C; Lalande V; Petit JC; Labia R; Arlet G
    J Antimicrob Chemother; 2005 Apr; 55(4):496-9. PubMed ID: 15722393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutant TEM beta-lactamase producing resistance to ceftazidime, ampicillins, and beta-lactamase inhibitors.
    Vakulenko S; Golemi D
    Antimicrob Agents Chemother; 2002 Mar; 46(3):646-53. PubMed ID: 11850243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel ceftazidime-resistance beta-lactamases generated by a codon-based mutagenesis method and selection.
    Gaytán P; Osuna J; Soberón X
    Nucleic Acids Res; 2002 Aug; 30(16):e84. PubMed ID: 12177312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic effects of functionally distinct substitutions in β-lactamase variants shed light on the evolution of bacterial drug resistance.
    Patel MP; Hu L; Brown CA; Sun Z; Adamski CJ; Stojanoski V; Sankaran B; Prasad BVV; Palzkill T
    J Biol Chem; 2018 Nov; 293(46):17971-17984. PubMed ID: 30275013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activity of ceftazidime/avibactam against isogenic strains of Escherichia coli containing KPC and SHV β-lactamases with single amino acid substitutions in the Ω-loop.
    Winkler ML; Papp-Wallace KM; Bonomo RA
    J Antimicrob Chemother; 2015 Aug; 70(8):2279-86. PubMed ID: 25957381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amino acid sequence determinants of beta-lactamase structure and activity.
    Huang W; Petrosino J; Hirsch M; Shenkin PS; Palzkill T
    J Mol Biol; 1996 May; 258(4):688-703. PubMed ID: 8637002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antagonism between substitutions in β-lactamase explains a path not taken in the evolution of bacterial drug resistance.
    Brown CA; Hu L; Sun Z; Patel MP; Singh S; Porter JR; Sankaran B; Prasad BVV; Bowman GR; Palzkill T
    J Biol Chem; 2020 May; 295(21):7376-7390. PubMed ID: 32299911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of changes in the L3 loop of the active site in the evolution of enzymatic activity of VIM-type metallo-beta-lactamases.
    Merino M; Pérez-Llarena FJ; Kerff F; Poza M; Mallo S; Rumbo-Feal S; Beceiro A; Juan C; Oliver A; Bou G
    J Antimicrob Chemother; 2010 Sep; 65(9):1950-4. PubMed ID: 20624761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Roles of amino acids 161 to 179 in the PSE-4 omega loop in substrate specificity and in resistance to ceftazidime.
    Therrien C; Sanschagrin F; Palzkill T; Levesque RC
    Antimicrob Agents Chemother; 1998 Oct; 42(10):2576-83. PubMed ID: 9756758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structures of ceftazidime and its transition-state analogue in complex with AmpC beta-lactamase: implications for resistance mutations and inhibitor design.
    Powers RA; Caselli E; Focia PJ; Prati F; Shoichet BK
    Biochemistry; 2001 Aug; 40(31):9207-14. PubMed ID: 11478888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.